コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ADPKD progression following inactivation of polycystins.
2 egorize the effects of missense mutations in polycystins.
3 n detected between the ARPKD FPC protein and polycystins.
4 or that represses cystogenesis distinct from polycystins.
7 ations in the PKD1 or PKD2 genes that encode Polycystin 1 and 2 (PC1/2), transmembrane proteins that
8 c kidney disease (PKD), genetic mutations in polycystin 1 and 2 lead to defective intracellular traff
11 ons in the PKD1 and PKD2 genes, encoding the polycystin 1 and polycystin 2 Ca(2+) ion channels, respe
13 The inactivation of the ciliary proteins polycystin 1 or polycystin 2 leads to autosomal dominant
17 TORC1 negatively regulates the biogenesis of polycystin-1 (PC-1) and trafficking of the PC-1/2 comple
20 aled that the protein and mRNA expression of polycystin-1 (PC1) and polycystin-2 (PC2) were increased
21 The ADPKD proteins encoded by these genes, polycystin-1 (PC1) and polycystin-2 (PC2), form a plasma
23 tations of the PKD1 and PKD2 genes, encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively,
24 gous mutations in PKD1 or PKD2, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively,
25 aused by mutations in PKD1 and PKD2 encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively.
26 encode the multipass transmembrane proteins polycystin-1 (PC1) and polycystin-2 (PC2), respectively.
27 is caused by mutations in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), which form an
33 ll subunits of the BBSome, the ADPKD protein polycystin-1 (PC1) interacts with BBS1, BBS4, BBS5 and B
40 ning disorder, commonly caused by defects in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubul
41 ve copy of either PKD1 or PKD2, which encode polycystin-1 (PC1) or polycystin-2 (PC2), respectively.
42 acid sequence, KVHPSST, in the C-terminus of polycystin-1 (PC1) that serves as a ciliary-targeting si
62 ncident collecting duct-specific knockout of polycystin-1 and AC6 (also homozygous for the floxed ADC
63 roteomic analysis confirmed that cleavage of polycystin-1 and fibrocystin occurs in vivo, in manners
66 cystin research, with a focus on the role of polycystin-1 and polycystin-2 in primary cilia and the c
67 y-membrane translocation of the PKD proteins polycystin-1 and polycystin-2 is compromised in DZIP1L-m
68 ycystic kidney disease (ADPKD) gene products polycystin-1 and polycystin-2 localize to both cilia and
70 y caused by the genes PKD1 or PKD2 (encoding polycystin-1 and polycystin-2, respectively) and ARPKD c
71 KD2, which encode the transmembrane proteins polycystin-1 and polycystin-2, respectively, cause autos
74 s with a novel ciliary targeting sequence of polycystin-1 and regulates polycystin-1 trafficking.
75 consistent with cleavage at the GPS site in polycystin-1 and the proprotein convertase site in fibro
81 define genetic and biochemical modulators of polycystin-1 function and provide a more complete defini
82 inhibition increases steady-state levels of polycystin-1 in cells lacking glucosidase IIbeta and tha
84 demonstrate, for the first time, a role for polycystin-1 in kidney injury and repair and indicate th
85 ibe a potential physiologic role for nephron polycystin-1 in the absence of cysts, tubule dilation, o
98 D, which displays a hypomorphic phenotype of polycystin-1, demonstrated increased cyst progression an
99 Vs) and isolated a subpopulation abundant in polycystin-1, fibrocystin (in their cleaved forms), and
100 In the Medicago lineage, nodule-specific Polycystin-1, Lipoxygenase, Alpha Toxin (PLAT) domain pr
101 nsertions in a M. truncatula nodule-specific polycystin-1, lipoxygenase, alpha-toxin (PLAT) domain-en
102 e investigated the role of the intracellular polycystin-1, lipoxygenase, and alpha-toxin (PLAT) signa
103 gene encodes a large transmembrane protein (polycystin-1, or PC-1) that is reported to function as a
104 tosomal recessive polycystic kidney disease (polycystin-1, polycystin-2, and fibrocystin) localize to
105 inergic Ca(2+) signaling may be regulated by polycystin-1, since ORPK cells only expressed the C-term
106 s in defective maturation and trafficking of polycystin-1, the central determinant of cyst pathogenes
108 regulated in cyst-lining epithelial cells in polycystin-1-deficient murine kidneys and accumulated in
111 egments in embryonic mouse kidney results in polycystin-1-mediated polycystic kidney disease (PKD).
112 It is unknown whether the Pkd1 gene product polycystin-1-the predominant causal factor in ADPKD-itse
115 yst development, either in genetic models of polycystin-1/2 reduction or in response to ischemia/repe
116 um binding from the membrane-targeting PLAT (polycystin-1/lipoxygenase/alpha-toxin) domain to the act
117 a role by which GPSM1 increased heteromeric polycystin-1/polycystin-2 ion channel activity via Gbeta
119 ase complex that targets the ciliary protein polycystin 2 (PC2) for degradation, but whether Nek and
120 e showed that the ER cation-permeant channel polycystin 2 (PC2) functions to reduce mitochondria-ER c
122 nvestigate the effect of decreased levels of polycystin 2 (PC2), a calcium channel that interacts wit
123 c1 functions by modulating the expression of polycystin 2 (Pkd2), a member of the transient receptor
126 olycystin-1 and transient receptor potential polycystin 2 (TRPP2) account for almost all clinically i
128 iliary function through its association with polycystin 2 and provides evidence of a further link bet
129 tin 2, dual morpholino-mediated knockdown of polycystin 2 and RP2 results in enhanced situs inversus,
132 nd PKD2 genes, encoding the polycystin 1 and polycystin 2 Ca(2+) ion channels, respectively, result i
135 tion of the ciliary proteins polycystin 1 or polycystin 2 leads to autosomal dominant polycystic kidn
136 ented the dorsal axis curvature formation in polycystin 2 morphants and curly up polycystin 2 mutants
139 s canonical binding site (EF-hand domain) of polycystin 2, a Ca(2+)-dependent channel with relevance
140 bserved physical interaction between RP2 and polycystin 2, dual morpholino-mediated knockdown of poly
141 ased notochord sheath collagen deposition in polycystin 2-deficient embryos is directly linked to axi
147 n 33 (TMEM33) interacts with the ion channel polycystin-2 (PC2) at the endoplasmic reticulum (ER) mem
154 ied a missense mutation in the gene encoding polycystin-2 (PC2) that prevented this protein from prop
155 nd mRNA expression of polycystin-1 (PC1) and polycystin-2 (PC2) were increased in jck mouse kidneys.
158 coded by these genes, polycystin-1 (PC1) and polycystin-2 (PC2), form a plasma membrane receptor-ion
159 y caused by defects in polycystin-1 (PC1) or polycystin-2 (PC2), in which tubular epithelia form flui
160 D proteins, termed as polycystin-1 (PC1) and polycystin-2 (PC2), interact via their C-termini to form
161 or PKD2, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively, cause autosomal domina
162 PKD2 genes, encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively, lead to autosomal domi
166 in the genes encoding polycystin-1 (PC1) and polycystin-2 (PC2), which form an ion channel complex th
168 e genes encoding polycystin-1 (PC1, PKD1) or polycystin-2 (PC2, PKD2) cause ADPKD, and PKD1 mutations
173 us work has indicated that sensory cilia and polycystin-2 (Pkd2), a cation channel, are required for
176 biochemically and genetically interacts with polycystin-2 (the protein product of the polycystic kidn
177 pting the recycling endosome reduces ciliary polycystin-2 and causes its accumulation in the recyclin
178 Our analysis showed that fibrocystin and polycystin-2 are dependent on IFT20, GMAP210, and the ex
179 he activation of which may reduce functional polycystin-2 below a critical threshold, precipitating t
180 the structural and mechanistic regulation of polycystin-2 by its TOP domain-a site with unknown funct
181 f PKD2 variants associated with ADPKD, where polycystin-2 channel dysregulation in the primary cilia
182 changes in the activation of the associated polycystin-2 channel or other intracellular events media
184 Biophysical properties of lacrimal gland polycystin-2 channels were similar to those described fo
185 is of immunogold labeling revealed strongest polycystin-2 expression on the membranes of the endoplas
187 ls generated from ADPKD patients do not show polycystin-2 in the cilia and are unable to sense fluid
189 ich GPSM1 increased heteromeric polycystin-1/polycystin-2 ion channel activity via Gbetagamma subunit
190 netic variants in PKD2 which encodes for the polycystin-2 ion channel are responsible for many clinic
191 ocation of the PKD proteins polycystin-1 and polycystin-2 is compromised in DZIP1L-mutant cells.
196 sease (ADPKD) gene products polycystin-1 and polycystin-2 localize to both cilia and EVs, act in the
198 solated artery, we further show that ciliary polycystin-2 responds specifically to shear stress and n
200 Thus, aberrant expression or localization of polycystin-2 to cilia could promote high blood pressure
201 normal expression level and localization of polycystin-2 to cilia is required for the endothelial ci
202 ciliary localization of the membrane protein Polycystin-2, a protein playing an important role in the
203 ive polycystic kidney disease (polycystin-1, polycystin-2, and fibrocystin) localize to various subce
204 the transport of ciliary components such as polycystin-2, and partial loss of this enzyme is suffici
206 that PDE1A activity is altered downstream of polycystin-2, and suggest that PDE1A is a viable drug ta
207 kDa, pericentriolar material protein 1, and polycystin-2, as well as the Golgi distribution of its b
208 n of the cilium and the ciliary transport of polycystin-2, as well as to alter proliferation signals
211 l channel-forming isoforms of TRPP channels (polycystin-2, polycystin-L, and polycystin-2L2) were exp
212 enes PKD1 or PKD2 (encoding polycystin-1 and polycystin-2, respectively) and ARPKD caused by PKHD1 (e
213 the transmembrane proteins polycystin-1 and polycystin-2, respectively, cause autosomal dominant pol
215 ARL13B is required for the ciliary entry of polycystin-2, the protein mutated in autosomal dominant
219 whose mutation impairs ciliary motility, and polycystin-2, whose ablation is associated with hydrocep
225 PP channels (polycystin-2, polycystin-L, and polycystin-2L2) were expressed in adult mouse lacrimal g
227 vel disease-associated protein families: The polycystins (ADPKD); fibrocystins (ARPKD); and meckelin.
228 a cystogenic activator that is inhibited by polycystins and an independent but relatively minor cyst
229 al a pathway connecting TNF-alpha signaling, polycystins and cystogenesis, the activation of which ma
230 with the signal transduction pathways of the polycystins and may control the targeting of these cilia
232 ressed cyst growth following inactivation of polycystins and that the severity of cystic disease was
241 esults from a reduction of ciliary levels of polycystins, Arl13b, and Arl13b-dependent lipidated carg
249 of genetic mechanisms, the structure of the polycystin complex and the roles of G-protein signalling
251 onal understanding of the putative PC-1/PC-2 polycystin complex is lacking due to technical hurdles i
252 lar localization and channel activity of the polycystin complex through its interaction with the O2-s
253 geting mechanism, whereby Rabep1 couples the polycystin complex to a GGA1/Arl3-based ciliary traffick
259 Brefeldin A treatment after the onset of polycystin deficiency phenotypes reversed the curved axi
260 ators of cardiac hypertrophy, are targets of polycystin-dependent fluid stress sensing in renal epith
261 sh the existence of a new pathway defined by polycystin-dependent inhibition and cilia-dependent acti
264 tein Tulp3 determines ciliary trafficking of polycystins in kidney collecting duct cells without affe
266 Kidney cysts occur following inactivation of polycystins in otherwise intact cilia or following compl
267 These data suggest a novel role for the polycystins in sensing and responding to cellular O2 lev
269 disease 2-like 1 (Pkd2l1 or Pkdl), encoding polycystin-L (PCL), a non-selective cation channel, incr
270 ing isoforms of TRPP channels (polycystin-2, polycystin-L, and polycystin-2L2) were expressed in adul
277 or cilia (acetylated tubulin, gamma-tubulin, polycystin [PC] 1, PC2, and KIF3A), fibroblasts (vimenti
278 logical experiments to determine whether the polycystins PC1 and PC2 (encoded by Pkd1 and Pkd2) and t
280 tations in Pkd1/Pkd2 and Pkhd1, which encode polycystins (PCs) and fibrocystin/polyductin (FPC).
282 localization of the kinesin-3 KLP-6 and the polycystin PKD-2 in male-specific sensory neurons in C.
287 ngth of time between the initial loss of the polycystin proteins and the subsequent involution of cil
289 on, maturation, or localization of the ADPKD polycystin proteins, with no interaction detected betwee
291 d new pathways controlling EV biogenesis and polycystin signaling and also identified EV cargo, which
292 tivated protein kinase (MAPK) pmk-1 acted in polycystin-signaling pathways controlling male mating be
293 e we demonstrate that TRPP2, a member of the polycystin subfamily of TRP channels encoded by the PKD2
294 ipocyte differentiation, indicating that the polycystins/TAZ complex may be a potential therapeutic t
297 made of transient receptor potential channel polycystin (TRPP) and polycystic kidney disease (PKD) pr
298 LOV-1 and PKD-2 transient receptor potential polycystin (TRPP) complex localizes to ciliated endings
299 se (ADPKD), a disease caused by mutations in polycystins, which are proteins that regulate signaling,
300 ses by combining conditional inactivation of polycystins with concomitant ablation of cilia in develo